Production (Stage)
Zenas BioPharma, Inc.
ZBIO
$11.43
-$0.02-0.18%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -162.76M | -156.99M | -128.97M | -54.76M | -45.83M |
| Total Depreciation and Amortization | 127.00K | 137.00K | 134.00K | 124.00K | 118.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.30M | 11.75M | 8.19M | 6.39M | 15.44M |
| Change in Net Operating Assets | 9.71M | 25.43M | 24.13M | 14.62M | 6.70M |
| Cash from Operations | -137.62M | -119.67M | -96.52M | -33.62M | -23.57M |
| Capital Expenditure | -127.00K | -131.00K | -74.00K | -74.00K | -39.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -116.68M | -30.42M | -26.76M | -- | -- |
| Cash from Investing | -116.80M | -30.55M | -26.83M | -74.00K | -39.00K |
| Total Debt Issued | -- | -- | 0.00 | 20.00M | 20.00M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 240.97M | 240.91M | 234.64M | 216.00K | 103.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 178.38M | 178.38M | 178.38M | 178.38M | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.68M | -6.33M | -1.86M | -1.42M | -656.00K |
| Cash from Financing | 413.67M | 412.96M | 411.16M | 197.18M | 19.45M |
| Foreign Exchange rate Adjustments | 69.00K | 157.00K | -71.00K | -15.00K | 119.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 159.31M | 262.89M | 287.73M | 163.47M | -4.04M |